Poulton Jeffrey V.
Alnylam Pharmaceuticals Inc · EVP
Poulton Jeffrey V. is listed in filings as EVP at Alnylam Pharmaceuticals Inc. This profile follows SEC Form 4 activity through Mar 6, 2026, including sale activity. Recent filings connect the profile to Alnylam Pharmaceuticals Inc (ALNY) and CervoMed Inc. (CRVO). The current snapshot covers public activity from Jun 14, 2024 to Mar 6, 2026. Reported amounts are shown as $264.9K to $99.4K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.